Cardiovascular drugs and exercise.
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000503:physiopathology; D002121:Calcium Channel Blockers / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000009:adverse effects*; D004070:Digitalis; D004232:Diuretics / Q000009:adverse effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D007537:Isometric Contraction; D005996:Nitroglycerin / Q000009:adverse effects; D005082:Physical Exertion; D010946:Plants, Medicinal; D010947:Plants, Toxic
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D004232:Diuretics; D005996:Nitroglycerin